SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-202341"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-202341" > Diagnosis and manag...

  • Kronbichler, AndreasMed Univ Innsbruck, Austria; Univ Cambridge, England; Med Univ Innsbruck, Austria (författare)

Diagnosis and management of ANCA-associated vasculitis

  • Artikel/kapitelEngelska2024

Förlag, utgivningsår, omfång ...

  • ELSEVIER SCIENCE INC,2024
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-202341
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-202341URI
  • https://doi.org/10.1016/S0140-6736(23)01736-1DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:155343987URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:for swepub-publicationtype

Anmärkningar

  • Funding Agencies|NIH/NIAID [UM1AI144295]; Autoimmunity Center of Excellence
  • Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis consists of two main diseases, granulomatosis with polyangiitis and microscopic polyangiitis, and remains among the most devastating and potentially lethal forms of autoimmune inflammatory disease. Granulomatosis with polyangiitis and microscopic polyangiitis are characterised by a necrotising vasculitis that can involve almost any organ, and have generally been studied together. The diseases commonly affect the kidneys, lungs, upper respiratory tract, skin, eyes, and peripheral nerves. Granulomatous inflammation and multinucleated giant cells are key pathological hallmarks of granulomatosis with polyangiitis, but are absent in microscopic polyangiitis. Many immune system events are essential to disease aetiopathogenesis, such as activation of the alternative complement pathway, neutrophil activation via complement receptors, and the influx of inflammatory cells, including monocytes and macrophages. These cells perpetuate inflammation and lead to organ damage. During the 21st century, the management of ANCA-associated vasculitis has moved away from reliance on cytotoxic medications and towards targeted biological medications for both the induction and maintenance of disease remission. Earlier diagnosis, partly the result of more reliable ANCA testing, has led to improved patient outcomes and better survival. Reductions in acute disease-related mortality have now shifted focus to long-term morbidities related to ANCA-associated vasculitis and their treatments, such as chronic kidney disease and cardiovascular disease. Therapeutic approaches in both clinical trials and clinical practice still remain too reliant on glucocorticoids, and continued efforts to reduce toxicity from glucocorticoids remain a priority in the development of new treatment strategies.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Bajema, Ingeborg M.Univ Med Ctr Groningen, Netherlands (författare)
  • Bruchfeld, AnnetteKarolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden; Karolinska Inst, Sweden(Swepub:liu)anbru14 (författare)
  • Kirsztajn, Gianna MastroianniUniv Fed Sao Paulo, Brazil (författare)
  • Stone, John H.Harvard Med Sch, MA USA (författare)
  • Med Univ Innsbruck, Austria; Univ Cambridge, England; Med Univ Innsbruck, AustriaUniv Med Ctr Groningen, Netherlands (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:The Lancet: ELSEVIER SCIENCE INC403:104270140-67361474-547X

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy